HTA
AGN

Haber Trilix Advisors’s Allergan plc AGN Stock Holding History

Haber Trilix Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$37K Buy
+290
New +$32.8K ﹤0.01% 271

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Haber Trilix Advisors's AGN Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in Allergan plc (AGN) in Q2 2013: 290 shares worth $37K. The stake represents ﹤0.01% of the portfolio and ranks #271 among its holdings.

512 funds tracked by Wall St. Rank hold AGN as of Q2 2013.

  • Haber Trilix Advisors held 290 shares of Allergan plc worth $37K as of Q2 2013.
  • Allergan plc was a new Haber Trilix Advisors position in Q2 2013.
  • Allergan plc made up ﹤0.01% of Haber Trilix Advisors's portfolio in Q2 2013, its #271 holding.
  • 512 funds tracked by Wall St. Rank held Allergan plc as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.